JP2023526536A5 - - Google Patents
Info
- Publication number
- JP2023526536A5 JP2023526536A5 JP2022571335A JP2022571335A JP2023526536A5 JP 2023526536 A5 JP2023526536 A5 JP 2023526536A5 JP 2022571335 A JP2022571335 A JP 2022571335A JP 2022571335 A JP2022571335 A JP 2022571335A JP 2023526536 A5 JP2023526536 A5 JP 2023526536A5
- Authority
- JP
- Japan
- Prior art keywords
- nebulizer
- rhil
- cov
- respiratory tract
- lower respiratory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063028494P | 2020-05-21 | 2020-05-21 | |
| US63/028,494 | 2020-05-21 | ||
| US202063072895P | 2020-08-31 | 2020-08-31 | |
| US63/072,895 | 2020-08-31 | ||
| PCT/IB2021/000347 WO2021234457A1 (en) | 2020-05-21 | 2021-05-20 | An inhaled il-1 blockade treatment for respiratory tract immunopathology |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023526536A JP2023526536A (ja) | 2023-06-21 |
| JP2023526536A5 true JP2023526536A5 (enExample) | 2024-05-28 |
Family
ID=76807913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022571335A Withdrawn JP2023526536A (ja) | 2020-05-21 | 2021-05-20 | 呼吸器免疫病態の吸入型ｉｌ－１遮断治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230210768A1 (enExample) |
| EP (1) | EP4153213A1 (enExample) |
| JP (1) | JP2023526536A (enExample) |
| KR (1) | KR20230015397A (enExample) |
| CN (1) | CN116348144A (enExample) |
| AU (1) | AU2021277585A1 (enExample) |
| CA (1) | CA3178404A1 (enExample) |
| MX (1) | MX2022014626A (enExample) |
| WO (1) | WO2021234457A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022006636A (es) * | 2019-12-02 | 2022-11-09 | Altavant Sciences Gmbh | Tratamiento de trastornos de las vías respiratorias bajas. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1565620A (zh) * | 2003-06-09 | 2005-01-19 | 上海复旦张江生物医药股份有限公司 | 白细胞介素－1受体拮抗剂治疗非典型性肺炎的用途 |
| HUE048024T2 (hu) * | 2006-08-10 | 2020-05-28 | Roy C Levitt | Anakinra bronchiolitis obliterans szindróma kezelésében való alkalmazásra |
| MX2022006636A (es) * | 2019-12-02 | 2022-11-09 | Altavant Sciences Gmbh | Tratamiento de trastornos de las vías respiratorias bajas. |
-
2021
- 2021-05-20 WO PCT/IB2021/000347 patent/WO2021234457A1/en not_active Ceased
- 2021-05-20 US US17/926,297 patent/US20230210768A1/en not_active Abandoned
- 2021-05-20 EP EP21739171.3A patent/EP4153213A1/en not_active Withdrawn
- 2021-05-20 JP JP2022571335A patent/JP2023526536A/ja not_active Withdrawn
- 2021-05-20 MX MX2022014626A patent/MX2022014626A/es unknown
- 2021-05-20 CN CN202180059453.XA patent/CN116348144A/zh active Pending
- 2021-05-20 KR KR1020227044455A patent/KR20230015397A/ko not_active Withdrawn
- 2021-05-20 CA CA3178404A patent/CA3178404A1/en active Pending
- 2021-05-20 AU AU2021277585A patent/AU2021277585A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20230005139A (ko) | 코로나바이러스 감염 및 이로 인한 염증-유발된 폐 손상의 치료 방법 | |
| JP2007532663A (ja) | ニューロパシー性の糖尿病性足潰瘍を治療するためのトレプロスチニルの使用 | |
| JP2002509074A (ja) | 熱ショックタンパク質を使用する、炎症性疾患を処置する方法 | |
| KR20250048093A (ko) | 최저 폐 기능 향상을 위한 엔시펜트린(rpl-554) | |
| JP2001199882A (ja) | 感冒・鼻炎用組成物 | |
| JP2023526536A5 (enExample) | ||
| US20060134008A1 (en) | Compositions and methods for pulmonary conditions | |
| RU2006132040A (ru) | Комбинация (варианты) и фармацевтический препарат для лечения заболеваний дыхательных путей | |
| KR20250086769A (ko) | 엔시펜트린을 이용한 특발성 폐섬유증 치료 | |
| CN113855685A (zh) | 糖皮质激素在制备治疗和/或预防呼吸道病毒感染的药物中的用途 | |
| JP2023520929A (ja) | コロナウイルス感染症の処置のための方法 | |
| CN114246937A (zh) | 白细胞介素37与干扰素联用在治疗病毒感染中的应用 | |
| CN101432002A (zh) | 治疗慢性阻塞性肺疾病的方法和组合物 | |
| CN115590858A (zh) | 一种环黄芪醇在制备抗哮喘药物中的应用 | |
| JP2021176903A (ja) | イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの応用 | |
| KR102872873B1 (ko) | 바이러스 감염증 치료용 약학 조성물 및 치료 방법 | |
| CN101068572A (zh) | 抗打鼾组合物 | |
| RU2305555C1 (ru) | Способ иммунокоррекции при пневмонии | |
| JP7607939B2 (ja) | 喘息を治療するための方法 | |
| WO2025146212A1 (zh) | N-[2-[[[4-(2,2-二甲基-1-氧代丙氧基)苯基]磺酰]氨基]苯甲酰]-(s)-甘氨酸或其盐的新用途 | |
| WO2026025266A1 (zh) | 京尼平-1-β-D龙胆双糖苷在制备治疗慢性阻塞性肺疾病药物中的应用 | |
| WO2023118014A1 (en) | Inhalable compositions comprising a complex of hpbcd and budesonide or ciclesonide for the treatment or prevention of a respiratory viral disease or lipopolysaccharide-induced inflammation, in particular lipopolysaccharide-induced inflammation associated with a respiratory viral disease | |
| CN116999538A (zh) | 一种治疗细胞因子风暴的药物及其应用 | |
| WO2008001055A1 (en) | Polyether polyols for use in the treatment and/or prevention of inflammatory lung disease | |
| TW202523336A (zh) | 醫藥溶液組合物及包含其之口腔霧化吸入劑型 |